Covid update

BioConnection, Contract Development and Manufacturing Organization, proudly announces that is has won the FD Gazellen status. This prestigious award is given by the Financieel Dagblad to financially healthy companies that have reached yearly revenue growth of more than 20% in the last 3 years.

Dr. Alexander Willemse, CEO of BioConnection: “We’re very excited to win one of the Gazelle awards. We have grown fast and steady in recent years. The highlight came early this year when we acquired the Aletta Jacobs building from MSD enabling us to
have our own manufacturing facility and expand our capabilities and capacity. It is also a reward for all the employees of BioConnection and their dedicated work and to our customers for their trust in us. We definitely look with confidence to the future.

About BioConnection B.V.

BioConnection B.V. ( is a Dutch contract development and manufacturing organization for the development and production of injectable (bio)pharmaceutical products. BioConnection specializes in: Drug Product development (formulation, analytics, lyophilisation), fill & finish and lyophilisation at clinical and commercial scale. BioConnection offers services based on tailor made solutions and customer-focused flexibility from its own plant and through our trusted partners.

About the FD Gazellen Award

To qualify for an FD Gazelle Award a company must have achieved net sales growth of at least 20 percent per year over the last 3 years. It is also important that the organization has a stable and healthy financial position. The most recent financial year should be concluded with a positive result and their may only be one year of financial loss in the previous period.

If you want to learn more about how BioConnection can bring value to your projects, please contact us.

Alexander Willemse, PhD


Sjaak Stevense, MD

Director Business Development


Covid-19 update BioConnection

BioConnection has taken precautions related to the global outbreak of the Covid-19 virus. To start with; we are currently in full operation and running on-schedule with regard to our planned productions. Our production department is on full strength and we have no shortages of material(s) nor do we foresee them.

For our personnel we are following the guidelines as issued by the Dutch National Institute for Public Health and the Environment, RIVM ( This means that people stay at home when they show (early) symptoms connected to Covid-19. Furthermore BioConnection employees work from home as much as possible. We avoid shaking hands and keep distance from each other. We take every precaution as advised to prevent the spread of the Covid-19 virus and will fully comply to the requests as stated and/or enforced by the authorities.

Our expansion project ( is running as planned to start GMP production in Q2 2021. We stay in close contact with our suppliers for the production equipment.

We review for Covid policy changes by the authorities on a daily base and adapt to them. If changes occur, this statement will be updated accordingly so you always have the latest information. In case you have any questions, please do not hesitate to contact us via our general number or website. Current customers of BioConnection, can contact their dedicated program manager. In case you want BioConnection to become a partner in your development or manufacturing, please contact our Business Development department via

The BioConnection Management Team.

You have Successfully Subscribed!